Net losses on financial instruments
Elevance Health Net losses on financial instruments decreased by 36.8% to -$78.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 83.2%, from -$464.00M to -$78.00M. Over 4 years (FY 2021 to FY 2025), Net losses on financial instruments shows a downward trend with a 19.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Frequent losses may indicate high-risk investment strategies or adverse market volatility, while gains contribute to non-operating profitability.
Detailed definition
Reflects the net impact of market value fluctuations on financial assets held by the company. This captures unrealized o...
Peer comparison
Common in insurance companies with large investment portfolios; often excluded from adjusted earnings metrics.
other_net_losses_gains_on_financial_instrumentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $172.00M | -$61.00M | $211.00M | -$151.00M | -$231.00M | -$57.00M | -$111.00M | -$113.00M | -$121.00M | -$124.00M | -$336.00M | -$161.00M | -$85.00M | -$125.00M | -$74.00M | -$464.00M | -$131.00M | -$1.00M | -$57.00M | -$78.00M |
| QoQ Change | — | -135.5% | +445.9% | -171.6% | -53.0% | +75.3% | -94.7% | -1.8% | -7.1% | -2.5% | -171.0% | +52.1% | +47.2% | -47.1% | +40.8% | -527.0% | +71.8% | +99.2% | <-999% | -36.8% |
| YoY Change | — | — | — | — | -234.3% | +6.6% | -152.6% | +25.2% | +47.6% | -117.5% | -202.7% | -42.5% | +29.8% | -0.8% | +78.0% | -188.2% | -54.1% | +99.2% | +23.0% | +83.2% |
Business Segments
| Segment | Q1 '25 |
|---|---|
| Reportable Segments | -$464.00M |
| Total | -$464.00M |
Net losses on financial instruments at Other Companies
Frequently Asked Questions
- What is Elevance Health's net losses on financial instruments?
- Elevance Health (ELV) reported net losses on financial instruments of -$78.00M in Q1 2026.
- How has Elevance Health's net losses on financial instruments changed year-over-year?
- Elevance Health's net losses on financial instruments increased by 83.2% year-over-year, from -$464.00M to -$78.00M.
- What is the long-term trend for Elevance Health's net losses on financial instruments?
- Over 4 years (2021 to 2025), Elevance Health's net losses on financial instruments has grown at a 19.3% compound annual growth rate (CAGR), from $322.00M to -$653.00M.
- What does net losses on financial instruments mean?
- The net gain or loss resulting from changes in the value of financial investments.